Home ›
Trademark Categories ›
Pharmaceuticals ›
2003 ›
NA ›
NABIDIOLEX
Trademark search for:
NABIDIOLEX
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2011-07-25 — Application filed
2011-07-28 — Application filed
2011-07-28 — Application filed
2011-08-02 — Teas voluntary amendment received
2011-08-15 — Assigned to lie
2011-08-25 — Preliminary/voluntary amendment - entered
2011-11-15 — Assigned to examiner
2011-11-18 — Assigned to examiner
2011-11-30 — Final disposition recorded
2011-11-30 — Final disposition recorded
2011-11-30 — Final disposition recorded
2012-05-29 — Office action issued
2012-06-06 — Teas/email correspondence entered
2012-06-06 — Correspondence received in law office
2012-07-09 — Final disposition recorded
2012-07-09 — Final disposition recorded
2012-07-09 — Final disposition recorded
2013-01-08 — Teas/email correspondence entered
2013-01-08 — Office action issued
2013-01-08 — Correspondence received in law office
2013-01-11 — Approved for pub - principal register
2013-01-11 — Law office publication review completed
2013-01-30 — Notification of notice of publication e-mailed
2013-02-19 — Published for opposition
2013-02-19 — Official gazette publication confirmation e-mailed
2013-04-16 — Noa e-mailed - sou required from applicant
2013-05-14 — Teas delete 1(b) basis received
2013-05-14 — Notice of allowance cancelled
2013-06-06 — Case assigned to intent to use paralegal
2013-06-06 — 1(b) basis deleted; proceed to registration
2013-07-16 — Registered-principal register
2017-11-29 — Attorney/dom.rep.revoked and/or appointed
2017-11-29 — Teas revoke/app/change addr of atty/dom rep received
2017-12-12 — Teas change of owner address received
2017-12-12 — Applicant/correspondence changes (non-responsive) entered
2018-07-16 — Courtesy reminder - sec. 8 (6-yr) e-mailed
2018-07-25 — Automatic update of assignment of ownership
2020-02-21 — Cancelled sec. 8 (6-yr)
2020-02-21 — Final status recorded
Owner Information
GW RESEARCH LIMITED
GW Pharma Limited
GW Pharma Limited
GW Pharma Limited
Correspondent
Anessa Owen Kramer Honigman Miller Schwartz and Cohn LLP
Filing Details
Filing Date:
Status Date:
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.
